This GEMM has combined genetic inactivation of Nf1 and the Cdkn2a alternate reading frame (Arf) that is deleted in 70–90% of NF1-associated ANNUBP and MPNST collectively17 and closely resembles patient samples. Here, CDKN2A is linked to malignant peripheral nerve sheath tumor.